4-74158254-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001144978.3(MTHFD2L):c.116T>A(p.Phe39Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000378 in 1,459,780 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001144978.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTHFD2L | NM_001144978.3 | c.116T>A | p.Phe39Tyr | missense_variant | 1/8 | ENST00000325278.7 | NP_001138450.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTHFD2L | ENST00000325278.7 | c.116T>A | p.Phe39Tyr | missense_variant | 1/8 | 5 | NM_001144978.3 | ENSP00000321984 | P1 | |
ENST00000600169.2 | n.120A>T | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 151918Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000629 AC: 4AN: 63592Hom.: 0 AF XY: 0.0000602 AC XY: 2AN XY: 33210
GnomAD4 exome AF: 0.000410 AC: 536AN: 1307862Hom.: 1 Cov.: 31 AF XY: 0.000403 AC XY: 257AN XY: 637512
GnomAD4 genome AF: 0.000105 AC: 16AN: 151918Hom.: 0 Cov.: 32 AF XY: 0.0000943 AC XY: 7AN XY: 74214
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 05, 2023 | The c.116T>A (p.F39Y) alteration is located in exon 1 (coding exon 1) of the MTHFD2L gene. This alteration results from a T to A substitution at nucleotide position 116, causing the phenylalanine (F) at amino acid position 39 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at